Description

Ultravist 370 (iopromide) 370 mg/ml. 100 ml. vial #1

Ultravist 370 is a contrast agent used in medical imaging procedures to enhance visibility of internal structures on X-rays, CT scans, and other imaging tests. The active ingredient in Ultravist 370 is iopromide, which is present at a concentration of 370 mg/ml. Each vial of Ultravist 370 contains 100 ml. of the contrast solution.

What is Ultravist 370 used for?

Ultravist 370 is commonly used in radiology departments and diagnostic centers for various imaging procedures, including:

• Computed Tomography (CT) scans
• Angiography
• Myelography
• Arthrography

By injecting Ultravist 370 into the body, healthcare providers can obtain clearer and more detailed images of organs, blood vessels, and other structures, helping to diagnose and monitor various medical conditions.

How does Ultravist 370 work?

Ultravist 370 is a type of iodinated contrast agent, which contains iodine atoms that absorb X-rays. When injected into the bloodstream or other body cavities, Ultravist 370 helps to enhance the contrast between different tissues and structures in the body. This increased visibility allows radiologists and healthcare providers to better visualize and analyze the internal anatomy during imaging procedures.

Administration and Dosage

Ultravist 370 is typically administered by injection, either intravenously or directly into the area being imaged. The dosage and administration protocol may vary depending on the specific imaging procedure and the patient’s individual characteristics, such as weight and medical history.

It is important to follow the healthcare provider’s instructions regarding the dosage, timing, and method of administration of Ultravist 370. Overdose or improper administration of the contrast agent can lead to adverse reactions and complications.

Possible Side Effects

While Ultravist 370 is generally considered safe and well-tolerated, some patients may experience side effects or adverse reactions to the contrast agent. Common side effects of Ultravist 370 may include:

• Nausea
• Headache
• Flushing
• Dizziness
• Injection site reactions

In rare cases, more serious side effects such as allergic reactions, kidney damage, or anaphylaxis may occur. Patients should inform their healthcare provider immediately if they experience any unexpected symptoms or adverse effects after receiving Ultravist 370.

Precautions and Warnings

Before using Ultravist 370, healthcare providers should consider the following precautions and warnings:

• Patients with a history of allergic reactions to iodinated contrast agents may be at an increased risk of experiencing adverse effects with Ultravist 370.
• Special caution should be taken when administering Ultravist 370 to patients with kidney impairment or other renal conditions, as the contrast agent may affect kidney function.
• Healthcare providers should be aware of potential drug interactions with Ultravist 370 and adjust the dosage or timing of administration accordingly.
• Pregnant or breastfeeding women should consult with their healthcare provider before undergoing imaging procedures with Ultravist 370, as the safety of the contrast agent in these populations is not well established.

It is important for healthcare providers to discuss the potential risks and benefits of using Ultravist 370 with each patient, taking into account their medical history, current medications, and overall health status.

Storage and Handling

Ultravist 370 should be stored according to the manufacturer’s instructions, typically in a cool, dry place away from direct sunlight and extreme temperatures. The vial should be checked for any signs of damage or contamination before use, and any expired or discolored solutions should be discarded properly.

Healthcare providers should follow proper aseptic techniques when handling Ultravist 370 to prevent contamination and maintain the sterility of the contrast agent. The vial should be used promptly after opening and any unused solution should be discarded according to institutional protocols.

Conclusion

Ultravist 370 is a valuable contrast agent used in medical imaging to improve the visualization of internal structures and facilitate accurate diagnosis of various medical conditions. By providing enhanced contrast in imaging studies, Ultravist 370 helps healthcare providers to obtain high-quality images for interpretation and clinical decision-making.

While Ultravist 370 is generally safe and effective when used appropriately, healthcare providers should be vigilant for potential side effects and adverse reactions in patients receiving the contrast agent. By following proper administration protocols, monitoring patients closely, and addressing any concerns promptly, healthcare providers can ensure the safe and successful use of Ultravist 370 in imaging procedures.